Back to User profile » Dr Shek-Ying Lin
Paper published by Dr Shek-Ying Lin:
Original Research
Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia
Yang QM, Hong JY, Ko YH, Lin SY, Au WY, Choi MK, Park S, Kim SJ, Kim WS
OncoTargets and Therapy 2014, 7:1717-1722
Published Date: 26 September 2014